Susquehanna Fundamental Investments’s Kyntra Bio KYNB Stock Holding History

Susquehanna Fundamental Investments’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.1M	Hold	3,665	–	–	0.02%	795
2021 Q4	$1.29M	Sell	3,665 -1,669	-31%	-$520K	0.03%	555
2021 Q3	$1.36M	Buy	5,334 +3,789	+245%	+$1.34M	0.03%	739
2021 Q2	$1.03M	Buy	+1,545	New	+$890K	0.02%	848
2021 Q1	–	Sell	-1,840	Closed	-$1.71M	–	1557
2020 Q4	$1.71M	Sell	1,840 -292	-14%	-$307K	0.03%	673
2020 Q3	$2.19M	Buy	2,132 +1,368	+179%	+$1.47M	0.07%	406
2020 Q2	$774K	Buy	+764	New	+$709K	0.04%	506

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Susquehanna Fundamental Investments's KYNB Position: Q1 2022 in Review

Susquehanna Fundamental Investments held its Kyntra Bio (KYNB) position steady in Q1 2022 at 3,665 shares worth $1.1M. The position accounts for 0.02% of the portfolio, ranked #795.

Susquehanna Fundamental Investments first reported a position in KYNB in Q2 2020 and has held it in 7 quarters since. The position peaked at $2.19M in Q3 2020. 156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.

Susquehanna Fundamental Investments held 3,665 shares of Kyntra Bio worth $1.1M as of Q1 2022.
Susquehanna Fundamental Investments left its Kyntra Bio share count unchanged in Q1 2022.
Kyntra Bio made up 0.02% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #795 holding.
Susquehanna Fundamental Investments first reported a position in Kyntra Bio in Q2 2020 and has held it in 7 quarters since.
Susquehanna Fundamental Investments's Kyntra Bio position peaked at $2.19M in Q3 2020.
156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.